Inactivating mutations of EZH2 are seen in myeloid disorders [45,46], while in 25% of T-ALL (T cell Acute Lymphoblastic Leukaemia), inactivating mutations are found, not only in EZH2, but also in SUZ12 [47]. The gene discussed is EZH2; the disease is acute lymphoblastic leukemia.